The UK government on Friday authorised the Moderna CCP virus vaccine, which became the third vaccine to be approved after the Pfizer/BioNTech and the Oxford/AstraZeneca jabs.
Regulatory approval was granted by the UK’s medicines regulator, the Medicines and Healthcare products Regulatory Agency (MHRA).
